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The field of metabonomics involves generation of complex
metabolic profiles of tissues and biofluids using analytical
p l a t f o r m ss u c ha sn u c l e a rm a g n e t i cr e s o n a n c e( N M R )
spectroscopy and mass spectrometry (MS). Metabolic pro-
files can reflect changes following an intervention, such as
administration of a drug or onset of a disease. Multivariate
modeling tools are applied to discriminate profiles and
identify biomarkers that differentiate between phenotypes
of interest such as control and diseased states. One advan-
tage of metabonomics is that it is a ‘top-down’ approach
that reflects an integrated systems response as it takes into
account genetic and environmental status. A variety of
analytical technologies can be utilized; however NMR
spectroscopy and MS represent the most powerful and
widely used tools as they can capture information on
thousands of metabolites in a biofluid in a single analytical
run. The challenge of extracting relevant metabolic infor-
mation from the complex spectral data sets is tackled
using pattern recognition tools that reduce the dimension-
ality of the data, such as principal components analysis
(PCA) and partial least squares regression (PLS) and many
novel statistically-driven approaches have been developed
in recent years.
An example of the application of metabonomics to dif-
ferentiate cerebrospinal fluid (CSF) samples from clinical
bacterial and viral meningitis cases was presented. The
application of NMR-based metabolic profiling greatly
improved the speed and specificity of sample classifica-
tion. In addition, patterns of CSF metabolites that altered
following bacterial and viral meningitis infection were
identifed. Furthermore, gram-stain negative samples of
meningococcal meningitis were clearly differentiated
from all other cases of bacterial meningitis. A larger
study is intended to validate these findings and to also
incorporate metabolic profiling of non-invasively col-
lected urine rather than CSF.
In terms of diagnostics, metabonomics has many diverse
application potentials and could be useful in studying the
metabolic signature reflecting host response, in identifying
pathogen-derived metabolites, and in differentiating single
infection versus co-infection. It may prove a powerful tool
for providing systems level insight into mechanisms of
pathology associated with infectious diseases, such as
Mycobacterium tuberculosis. With respect to therapeutic
monitoring, both in vitro and in vivo metabonomic-led
approaches could offer insight into the response of both
the pathogen and host to intervention, drug resistance,
therapeutic efficacy and toxicology.
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